Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, MRCP-ll(UK)
Consultant Physician
MBBS, FCPS (Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine), MRCP-UK, MACP (USA), Dip in Endocrinology UKAP (UK)
Internal Medicine Specialist
MBBS, FCPS (Medicine), MRCP-UK, MACP (USA), Dip in Endocrinology UKAP (UK)
Gastroenterologist
MBBS, FCPS (Gastroenterology), European Speciality Certificate in Gastroenterology and Hepatalogy (UK)
Gastroenterologist
MBBS, FCPS (Gastroenterology), European Speciality Certificate in Gastroenterology and Hepatalogy (UK)
Consultant Physician
M.B.B.S, F.C.P.S (Medicine)
Endocrinologist
M.B.B.S., F.C.P.S., Fellowship in Diabetes & Endocrine
Gastroenterologist
MBBS, FCPS (Gastroenterology)
General Physician
MBBS, MCPS (Family Medicine), Diploma in Diabetes Management, Diploma in Family Health Care
General Physician
MBBS, MCPS (Family Medicine), Diploma in Diabetes Management, Diploma in Family Health Care
Internal Medicine Specialist
MBBS, MRCP (UK)
Dermatologist
M.B.B.S, M.R.C.P (UK)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures